FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Syndicate content

Inviragen News

Most Popular Inviragen Story

Inviragen, PharmaJet land $15.5M for needle-free dengue vax

The National Institute of Allergy and Infectious Diseases awarded a five-year, $15.5 million contract to Inviragen and PharmaJet to continue their work on a needle-free dengue vaccine. The disease, Read more...

Inviragen Press Releases

  • Inviragen and University of Texas Medical Branch Receive Funding for Development of a Novel Recombinant Chikungunya Virus Vaccin
  • International Vaccine Institute and Inviragen announce a collaboration to accelerate development of a dengue vaccine
  • International Vaccine Institute and Inviragen Announce a Collaboration to Accelerate Development of a Dengue Vaccine
  • Inviragen and Duke-NUS Form Collaborative Vaccine Research and Development Program
  • Inviragen Initiates DENVax Phase 1 Clinical Testing in Colombia

Latest Headlines